These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 393102)

  • 1. Penicillamine in rheumatoid arthritis.
    Hill AG; Hill HF
    Agents Actions Suppl; 1979; (5):129-38. PubMed ID: 393102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent treatment with D-penicillamine is effective in lower doses and with fewer adverse effects in patients with rheumatoid arthritis.
    Hakoda M; Taniguchi A; Kamatani N; Akahoshi T; Kashiwazaki S
    J Rheumatol; 1994 Sep; 21(9):1637-41. PubMed ID: 7799341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.
    Capell HA; Marabani M; Madhok R; Torley H; Hunter JA
    Q J Med; 1990 Apr; 75(276):335-44. PubMed ID: 1974723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The side effects of penicillamine therapy in rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1981; 7():146-8. PubMed ID: 6939876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [D-penicillamine--a current review of areas of use and dosage guidelines].
    Sörensen H
    Z Rheumatol; 1988; 47 Suppl 1():13-6. PubMed ID: 3063002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [D-penicillamine therapy in rheumatoid arthritis: adverse reactions with 2 different administration regimens].
    Fernández Dapica P; Peña J; Merino J; Casanueva B; Morillas L; Mateo I; Rodríguez-Valverde V; Gómez-Reino J
    Med Clin (Barc); 1984 Jun; 83(5):184-7. PubMed ID: 6482577
    [No Abstract]   [Full Text] [Related]  

  • 8. Maintenance dose of penicillamine in rheumatoid arthritis: a comparison between a standard and a response-related flexible regimen.
    Hill HF; Hill AG; Day AT; Brown RM; Golding JR; Lyle WH
    Ann Rheum Dis; 1979 Oct; 38(5):429-33. PubMed ID: 518142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status of D-penicillamine therapy in chronic polyarthritis].
    Franke M; Menning H; Ströbel G
    Z Rheumatol; 1981; 40(2):54-61. PubMed ID: 7282106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penicillamine for rheumatoid arthritis.
    Med Lett Drugs Ther; 1978 Aug; 20(17):73-4. PubMed ID: 355819
    [No Abstract]   [Full Text] [Related]  

  • 12. An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy.
    Webley M; Coomes EN
    J Rheumatol; 1979; 6(1):20-4. PubMed ID: 439106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
    van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
    J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillamine treatment of rheumatoid arthritis with a single daily dose of 250 mg.
    Jaffe IA
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):130. PubMed ID: 122661
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis: disease-modifying antirheumatic drugs.
    Kirwan JR; Currey HL
    Clin Rheum Dis; 1983 Dec; 9(3):581-99. PubMed ID: 6360514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Direct, immediate and late results of the treatment of rheumatoid arthritis with D-penicillamine].
    Matveĭkov GP; Zhivutskiĭ II; Koshelev VK; Pshonik SS
    Vopr Revm; 1978; (4):6-12. PubMed ID: 364835
    [No Abstract]   [Full Text] [Related]  

  • 18. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.
    Dixon AJ; Davies J; Dormandy TL; Hamilton EB; Holt PJ; Mason RM; Thompson M; Weber JC; Zutshi DW
    Ann Rheum Dis; 1975 Oct; 34(5):416-21. PubMed ID: 769707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A; Rothfield NF
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.